Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Takeda and Zinfandel begin phase III trial to delay MCI in Alzheimer's disease

Aug. 27, 2013

Alcobra enrolls first patient in predominantly inattentive ADHD study

Aug. 27, 2013

KemPharm reports data from KP-201 study

Aug. 27, 2013

New P2X receptor antagonists described by Shionogi & Co.

Aug. 27, 2013

New MGPEG-2 inhibitors presented by Glenmark Pharmaceutical

Aug. 26, 2013

The development of new animal models for the study of human prion diseases

Aug. 26, 2013

Pfizer discloses novel sodium channel blockers for pain

Aug. 23, 2013

Navidea receives NIH grant, enters into agreement with Siemens' PETNET Solutions for imaging agent

Aug. 22, 2013

Nicotinic acetylcholine receptor ligands patented by Targecept

Aug. 22, 2013

ISCO and Duke University sign research agreement

Aug. 22, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...